Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,000
Closed -$2.22M 4505
2022
Q4
$2.22M Hold
25,000
﹤0.01% 2859
2022
Q3
$2M Buy
+25,000
New +$2.36M ﹤0.01% 3013
2019
Q1
Sell
-4,600
Closed -$295K 3632
2018
Q4
$295K Hold
4,600
﹤0.01% 3354
2018
Q3
$364K Buy
+4,600
New +$356K ﹤0.01% 3281

Other funds holding CNMD

David Shaw's CNMD Position: Q2 2026 in Review

David Shaw increased its CONMED (CNMD) stake by 42% in Q2 2026, buying an estimated $730K and bringing the position to 68,134 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3103.

David Shaw first reported a position in CNMD in Q3 2013 and has held it in 36 quarters since. The position peaked at $15.7M in Q4 2014. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • David Shaw held 68,134 shares of CONMED worth $2.23M as of Q2 2026.
  • David Shaw bought 20,283 CONMED shares in Q2 2026, an estimated $730K.
  • CONMED made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3103 holding.
  • David Shaw first reported a position in CONMED in Q3 2013 and has held it in 36 quarters since.
  • David Shaw's CONMED position peaked at $15.7M in Q4 2014.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.